... between the two age groups. "MSC trials in older patients have been a controversial topic in the field of stem cell research," Says Dr. Hare. "Many of the cardiac conditions we aim to cure are more prevalent in the older population. The hope is that ...
http://ift.tt/1wPx8c4
http://ift.tt/1wPx8c4
No comments:
Post a Comment